Does Tianjin Pharmaceutical Da Ren Tang Group have an economic moat?
Likely
Tianjin Pharmaceutical Da Ren Tang Group earns 20.6% a year on the money invested in it and keeps 74% of every sale after production costs, the numbers of a business competitors struggle to copy.
The numbers behind it
Return on invested capital, average of recent years20.6%
Return on invested capital, latest year28.9%
Gross margin74.0%Share of each sale left after production costs
Net margin43.3%
How we decide
A moat shows up in the numbers as high returns that last. We call it likely when the average return on invested capital over recent years is at least 15% and the gross margin at least 40%, and possible from 10%. The numbers can't show where a moat comes from (brand, network, patents), only that one seems to exist.
More questions about Tianjin Pharmaceutical Da Ren Tang Group
Data as of Nov 13, 2026.